News
Reported first quarter 2025 revenues of $87.1 million with 62% year-over-year growth of exome and genome test revenue.
Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...
Emma Weston joined the clinical trial after running out of treatment options. For two years, she's been cancer free.
South Shore Health's Dr. Todd Ellerin says the drug, a form of immunotherapy, is not FDA-approved, but it is on a groundbreaking fast track.
T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety profile in patients with two types of advanced thyroid cancer, according to ...
Angela Goodrich, 45, was shocked to be diagnosed with an extremely rare cancer. She shared her story and symptoms with TODAY.com before she passed away.
“99% of all colon cancers start as a polyp, so if they are removed, you shouldn't ever get colon cancer.The problem today is ...
University Medical Center Tucson has made history as the first hospital in Arizona to utilize Aliya Pulsed Electric Field ...
All of a sudden we were just thrown into having to learn everything imaginable the same day that he needed to start shots,” ...
According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...
Paul Hunter was one of the most popular and talented snooker players of his generation, but his life was cruelly cut short ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results